United States Personalized Medicine Market 2025 | Industry Developments, Future Growth, Share & Industry Insights

Personalized Medicine Market reached US$ 538.25 billion in 2023 and is expected to reach US$ 976.30 billion by 2031 growing with a CAGR of 7.8% during the forecast period 2024-2031.

DataM Intelligence unveils its latest report on the "Personalized Medicine Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/personalized-medicine-market?sg

List of Top Key Player: Abbott, GE HealthCare., Danaher Corporation (Cepheid, Inc.), ASURAGEN, INC., Exact Sciences Corporation, Illumina, Inc., QIAGEN, Genentech, Inc., Biogen, and IBM.

United States - Industry Developments:

✅ Eli Lilly Acquires Verve Therapeutics
In June 2025, Eli Lilly acquired gene-editing biotech Verve Therapeutics for up to $1.3 billion, aiming to enhance its cardiovascular portfolio with CRISPR-based therapies targeting cholesterol-related genes.

✅ Gilead Acquires Interius
In August 2025, Gilead acquired Interius for $350 million to advance in vivo CAR-T cell therapy, strengthening its personalized oncology pipeline.

Japan - Industry Developments:

✅ Japan's Precision Medicine Market Growth
As of 2025, Japan's precision medicine market is experiencing robust growth, driven by advancements in genomics and personalized therapies.

✅ 3D Bioprinting in Personalized Medicine
Japan is investing in 3D bioprinting technologies to create personalized tissue models for drug testing and regenerative medicine.

South Korea - Industry Developments:

✅ South Korea's Precision Medicine Advancements
In 2025, South Korea continues to lead in precision medicine, with significant investments in genomics and personalized healthcare solutions.

Europe - Industry Developments:

✅ Sanofi Acquires Blueprint Medicines
In June 2025, Sanofi acquired U.S.-based Blueprint Medicines for over $9 billion, enhancing its portfolio in rare immunological diseases and precision medicine.

✅ Hu-PreciMED Project in France
France launched the Hu-PreciMED project, a collaborative initiative involving over 45 medical and digital companies to advance precision medicine.

Forecast Projection:

The Global Personalized Medicine Market is poised for significant growth between 2025 and 2032. In 2024, the market maintained a steady upward trajectory, and with strategic initiatives by leading players accelerating adoption, the market is expected to soar throughout the forecast period. Companies leveraging these trends are well-positioned to capture emerging opportunities and maximize revenue potential.

Market Intelligence Research Process:

The Personalized Medicine Market research report by DataM Intelligence combines primary and secondary data to deliver deep, actionable insights. It examines the full spectrum of factors shaping the industry, from government regulations and market conditions to competitive dynamics, historical trends, technological breakthroughs, upcoming innovations, and potential challenges. This comprehensive analysis not only highlights growth prospects but also identifies barriers, equipping businesses to navigate market volatility and capitalize on emerging opportunities.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=personalized-medicine-market?sg

Key Segmentation:

By Product Type (Personalized Medicine Therapeutics, Personalized Medical Care)

By Application (Oncology, Neurology, Cardiology, Psychiatry, Immunology, Others)

By End-User (Hospitals & Specialty Care, Diagnostic Centers, Research & Academic Institutes, Others)

By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Global Growth Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1 - Market Overview: Kickstarts the report with a comprehensive snapshot of the Personalized Medicine Market, summarizing key segments by region, product type, and application. Highlights include market size, segment growth potential, and short- & long-term industry outlook.

Chapter 2 - Emerging Trends: Uncovers the game-changing trends and high-impact innovations shaping the future of the industry.

Chapter 3 - Competitive Landscape: Offers a deep dive into market competition, detailing revenue shares, strategic initiatives, and recent mergers & acquisitions.

Chapter 4 - Top Player Profiles: Features detailed company profiles, covering revenue, profit margins, product lines, and major milestones for leading market players.

Chapters 5 & 6 - Regional & Country Analysis: Breaks down revenue performance across global regions, providing insights on market sizes, opportunities, and growth prospects worldwide.

Chapter 7 - Segmentation Analysis: Explores market segmentation by type, revealing high-potential categories and guiding businesses towards lucrative areas.

Chapter 8 - Application Insights: Examines downstream markets and identifies promising sectors for expansion, showing how different applications are driving growth.

Chapter 9 - Supply Chain Mapping: Maps the entire industry supply chain, highlighting upstream and downstream activities for a holistic market perspective.

Chapter 10 - Key Takeaways: Concludes with critical insights and actionable strategies, equipping stakeholders to make informed decisions and stay ahead in the market.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/personalized-medicine-market?sg

FAQ's

Q1: What is the current size of the Personalized Medicine Market and its future potential?

A: The Personalized Medicine Market was valued at US$ 538.25 billion in 2023 and is projected to surge to US$ 976.30 billion by 2031

Q2: How fast is the Personalized Medicine Market expected to grow in the coming years?

A: The market is forecast to expand at a robust CAGR of 7.8% between 2024-2031, signaling strong global growth and investment potential.

Q3: Which regions are dominating the Personalized Medicine Market and which are fastest-growing?

A: North America region is expected to hold the largest market share over the forecast period

Request 2 Days Free Trials with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sg

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.